Mitoxantrone, etoposide and cytarabine following epigenetic priming with decitabine in adults with relapsed/refractory acute myeloid leukemia or other high-grade myeloid neoplasms: a phase 1/2 study

Anna B. Halpern,Megan Othus,Emily M. Huebner,Sarah A. Buckley,Era L. Pogosova-Agadjanyan,Kaysey F. Orlowski,Bart L. Scott,Pamela S. Becker,Paul C. Hendrie,Tara L. Chen,Mary-Elizabeth M. Percival,Elihu H. Estey,Derek L. Stirewalt,Roland B. Walter

Mitoxantrone, etoposide and cytarabine following epigenetic priming with decitabine in adults with relapsed/refractory acute myeloid leukemia or other high-grade myeloid neoplasms: a phase 1/2 study

2017

Anna B. Halpern
Megan Othus
Emily M. Huebner
Sarah A. Buckley
Era L. Pogosova-Agadjanyan
Kaysey F. Orlowski
Bart L. Scott
Pamela S. Becker
Paul C. Hendrie
Tara L. Chen
Mary-Elizabeth M. Percival
Elihu H. Estey
Derek L. Stirewalt
Roland B. Walter

Mitoxantrone, etoposide and cytarabine following epigenetic priming with decitabine in adults with relapsed/refractory acute myeloid leukemia or other high-grade myeloid neoplasms: a phase 1/2 study

Keywords:

Etoposide
Cancer research
Decitabine
Priming (psychology)
Myeloid
Epigenetics
Myeloid leukemia
Mitoxantrone
Cytarabine
Medicine
Refractory

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations